NO20061999L - Anvendelse av syliske anabaenopeptin-type peptider for behandling av en tilstand hvor inhibering av karboksypeptidase U er fordelaktig, nye anabaenopeptin-derivater og mellomprodukter derav - Google Patents
Anvendelse av syliske anabaenopeptin-type peptider for behandling av en tilstand hvor inhibering av karboksypeptidase U er fordelaktig, nye anabaenopeptin-derivater og mellomprodukter deravInfo
- Publication number
- NO20061999L NO20061999L NO20061999A NO20061999A NO20061999L NO 20061999 L NO20061999 L NO 20061999L NO 20061999 A NO20061999 A NO 20061999A NO 20061999 A NO20061999 A NO 20061999A NO 20061999 L NO20061999 L NO 20061999L
- Authority
- NO
- Norway
- Prior art keywords
- anabaenopeptin
- carboxypeptidase
- inhibition
- intermediates
- cyclic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0302853A SE0302853D0 (sv) | 2003-10-29 | 2003-10-29 | Chemical compounds |
PCT/SE2004/001568 WO2005039617A1 (en) | 2003-10-29 | 2004-10-28 | Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061999L true NO20061999L (no) | 2006-07-27 |
Family
ID=29580155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061999A NO20061999L (no) | 2003-10-29 | 2006-05-04 | Anvendelse av syliske anabaenopeptin-type peptider for behandling av en tilstand hvor inhibering av karboksypeptidase U er fordelaktig, nye anabaenopeptin-derivater og mellomprodukter derav |
Country Status (22)
Country | Link |
---|---|
US (1) | US20080039376A1 (uk) |
EP (1) | EP1689424A1 (uk) |
JP (1) | JP2008501622A (uk) |
KR (1) | KR20060132596A (uk) |
CN (1) | CN1897963A (uk) |
AR (1) | AR046612A1 (uk) |
AU (1) | AU2004283643B2 (uk) |
BR (1) | BRPI0415964A (uk) |
CA (1) | CA2543630A1 (uk) |
CO (1) | CO5690614A2 (uk) |
IL (1) | IL175198A0 (uk) |
IS (1) | IS8471A (uk) |
MY (1) | MY143363A (uk) |
NO (1) | NO20061999L (uk) |
RU (1) | RU2365594C2 (uk) |
SA (1) | SA05250463B1 (uk) |
SE (1) | SE0302853D0 (uk) |
TW (1) | TW200524576A (uk) |
UA (1) | UA85199C2 (uk) |
UY (1) | UY28585A1 (uk) |
WO (1) | WO2005039617A1 (uk) |
ZA (1) | ZA200603355B (uk) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106716320B (zh) | 2014-09-30 | 2020-10-30 | 苹果公司 | 用于电子设备的可配置的力敏输入结构 |
TWI649686B (zh) | 2015-09-30 | 2019-02-01 | 美商蘋果公司 | 具有適應性輸入列之鍵盤 |
LT3464336T (lt) | 2016-06-01 | 2022-05-10 | Athira Pharma, Inc. | Junginiai |
US10732743B2 (en) | 2017-07-18 | 2020-08-04 | Apple Inc. | Concealable input region for an electronic device having microperforations |
EP3676283A4 (en) * | 2017-09-01 | 2021-06-09 | Alsonex Pty Ltd | METHOD OF SOLID PHASE SYNTHESIS OF CYCLIC PENTAPEPTIDES |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9524630D0 (en) * | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
KR20030022412A (ko) * | 2000-08-17 | 2003-03-15 | 화이자 인코포레이티드 | TAFIa 억제제인 치환된 이미다졸 |
-
2003
- 2003-10-29 SE SE0302853A patent/SE0302853D0/xx unknown
-
2004
- 2004-10-27 MY MYPI20044426A patent/MY143363A/en unknown
- 2004-10-28 WO PCT/SE2004/001568 patent/WO2005039617A1/en active Application Filing
- 2004-10-28 KR KR1020067010392A patent/KR20060132596A/ko not_active Application Discontinuation
- 2004-10-28 US US10/578,022 patent/US20080039376A1/en not_active Abandoned
- 2004-10-28 RU RU2006117821/04A patent/RU2365594C2/ru not_active IP Right Cessation
- 2004-10-28 AU AU2004283643A patent/AU2004283643B2/en not_active Ceased
- 2004-10-28 UA UAA200604776A patent/UA85199C2/uk unknown
- 2004-10-28 JP JP2006537936A patent/JP2008501622A/ja not_active Withdrawn
- 2004-10-28 UY UY28585A patent/UY28585A1/es not_active Application Discontinuation
- 2004-10-28 CA CA002543630A patent/CA2543630A1/en not_active Abandoned
- 2004-10-28 EP EP04793868A patent/EP1689424A1/en not_active Withdrawn
- 2004-10-28 BR BRPI0415964-0A patent/BRPI0415964A/pt not_active IP Right Cessation
- 2004-10-28 CN CNA2004800390596A patent/CN1897963A/zh active Pending
- 2004-10-29 TW TW093132865A patent/TW200524576A/zh unknown
- 2004-11-01 AR ARP040104004A patent/AR046612A1/es unknown
-
2005
- 2005-01-29 SA SA05250463A patent/SA05250463B1/ar unknown
-
2006
- 2006-04-25 IL IL175198A patent/IL175198A0/en unknown
- 2006-04-26 ZA ZA200603355A patent/ZA200603355B/en unknown
- 2006-05-04 NO NO20061999A patent/NO20061999L/no not_active Application Discontinuation
- 2006-05-16 IS IS8471A patent/IS8471A/is unknown
- 2006-05-23 CO CO06049388A patent/CO5690614A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU2004283643A1 (en) | 2005-05-06 |
MY143363A (en) | 2011-04-29 |
UY28585A1 (es) | 2005-05-31 |
SE0302853D0 (sv) | 2003-10-29 |
JP2008501622A (ja) | 2008-01-24 |
IS8471A (is) | 2006-05-16 |
EP1689424A1 (en) | 2006-08-16 |
UA85199C2 (uk) | 2009-01-12 |
RU2006117821A (ru) | 2007-12-10 |
RU2365594C2 (ru) | 2009-08-27 |
US20080039376A1 (en) | 2008-02-14 |
CA2543630A1 (en) | 2005-05-06 |
TW200524576A (en) | 2005-08-01 |
KR20060132596A (ko) | 2006-12-21 |
CN1897963A (zh) | 2007-01-17 |
SA05250463A (ar) | 2005-12-03 |
ZA200603355B (en) | 2007-07-25 |
SA05250463B1 (ar) | 2009-02-07 |
BRPI0415964A (pt) | 2007-01-23 |
IL175198A0 (en) | 2006-09-05 |
AR046612A1 (es) | 2005-12-14 |
CO5690614A2 (es) | 2006-10-31 |
AU2004283643B2 (en) | 2008-07-10 |
WO2005039617A1 (en) | 2005-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20041041L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
IL171977A (en) | Cyclic sulfonamide for inhibition of gamma-secretase, process for its preparation and a pharmaceutical composition comprising the same | |
NO20055565L (no) | Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO) | |
NO20051600L (no) | 1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer | |
BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
IN2015DN01132A (uk) | ||
NO20060706L (no) | Inhibitorer av serinproteaser, spesielt HCV NS3-NS4A-protease | |
BR0209468A (pt) | Composto ou sais ou solvatos deste farmaceuticamente aceitáveis, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada pelo hppar | |
WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
WO2004037789A3 (en) | Methylene urea derivatives as raf-kinase inhibitors | |
MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
NO20085077L (no) | Nye forbindelser | |
DE60325074D1 (de) | Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält | |
BRPI0307351B8 (pt) | composto, composição farmacêutica, uso de um composto, e, processo para preparar um composto | |
RU94036772A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования эндометриоза | |
IL165264A (en) | Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases | |
NO20051962L (no) | Fenetanolaminderivater for behandling av respiratoriske sykdommer | |
HUP0402376A2 (hu) | Imidazol-4-karboxamid-származékok, előállításuk és az ezeket tartalmazó, elhízás kezelésére alkalmas gyógyszerkészítmények | |
RU94036758A (ru) | Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома | |
ECSP055809A (es) | Inhibidores 4-oxo-1-(3-fenil sustituido)-1,4-dihidro-1,8-naftiridina-3-carboxamida de la fosfodiesterasa-4 | |
BR0317294A (pt) | Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com a glicogênio sintase quinase-3 e de prevenção e/ou tratamento de doenças, e, uso dos intermediários | |
RU94045846A (ru) | Применение производных бензотиофена для ингибирования тромбина | |
DE60234577D1 (de) | Pharmazeutische mischung zur behandlung von krebs, die dioxolan nukleosidanalogen enthält | |
RU94045149A (ru) | Средство ингибирования легочных гипертонических заболеваний | |
NO20060146L (no) | Benzimidazolderivater, sammensetninger som inneholder slike, fremstilling derav og anvendelse derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |